Is Amneal Stock a Buy After Investment Firm Westshore Wealth Bought Over 1 Million Shares?

The pharmaceutical company has experienced sales growth over the past five years.On November 17, 2025, financial services firm Westshore Wealth, LLC disclosed a new position in Amneal Pharmaceuticals (AMRX +0.00%), acquiring 1,381,910 shares valued at approximately $13.83 million.Westshore initiated a stake in Amneal in the third quarter, buying 1,381,910 shares.The transaction accounted for 4.73% of Westshore Wealth's 13F reportable assets under management.Post-trade, Westshore's total stake in Amneal was ...